Lupin has always been very shy in discussing their drug discovery pipeline. However, in an exclusive interview with CNBC-TV18, Dr Kamal Sharma, said that the company is excited about the R&D pipeline, which has 10 lead molecules, and could be potential out-licencing targets by next year.
first published: Nov 16, 2011 07:20 pm
A collection of the most-viewed Moneycontrol videos.
Oil Shock: India’s Oil Security at Stake | Is an LNG Shock Coming for India? | Commodities with MC
Monday Mayhem in markets| Brent surges 18%, Global markets slide 2-8% | Nifty Set for Gap Down Open
PM Modi Speech: PM Modi Accuses TMC of Insulting President Murmu and Constitution
India Markets Not Cheap Right Now? CIO Rajesh Bhatia Flags Risks
